Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe SepsisEdward Abraham, Abla A. Creasey, Christopher J. Doig et al.|JAMA|2003Cited by 958
A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumoniaPierre-François Laterre, Richard G. Wunderink, Steven M. Opal et al.|Critical Care|2009Cited by 45